Organon & Co (OGN) stock news · rev $6.22B
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
This OGN news page leads with what Organon & Co filed — not a scraped headline mill.
No cached 8-K sentence for OGN yet. We will not pad this page with generic market recap.
Latest reported OGN revenue for 2025-12-31 was $6.22B. Net income was $187.0M. Revenue was down 2.9% from 2024-12-31 to 2025-12-31. OGN currently screens at market cap $2.52B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the OGN stock page; for the tape open the quote page.
OGN stock news FAQ
What are OGN's latest revenue and net income?
Latest cached Organon & Co (OGN) revenue for Dec 31, 2025 was $6.22B. Net income was $187.0M. Statements: https://lician.com/financials/ogn
How did OGN revenue change from the prior cached period?
Cached Organon & Co (OGN) revenue was down 2.9% from $6.40B (Dec 31, 2024) to $6.22B (Dec 31, 2025). Statements: https://lician.com/financials/ogn
What is OGN's market cap?
Organon & Co (OGN) market cap is $2.52B on the latest cached fundamentals snapshot.
What kind of company is OGN?
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Where is OGN stock news listed?
Cached stock news for Organon & Co (OGN) is listed at https://lician.com/news/ogn. Filings: https://lician.com/sec/ogn
Not investment advice.